The Latest Cardiac and Vascular News
NEW YORK, Oct. 2, 2018 /PRNewswire/ — Xtreem Pulse LLC is pleased to announce that PureFlow received 510Kclearance from the FDA for chronic stable angina that is refractory to optimal anti-anginal medical therapy and without option for revascularization. Intended for use in healthy patients to provide improvement in vasodilation, increased VO2, and increased […]
HONOLULU, Oct. 2, 2018 /PRNewswire/ — Cardax, Inc. (OTCQB: CDXI) has launched its Cardiovascular Health Astaxanthin Supplement Evaluation (CHASE) clinical trial targeting cardiovascular inflammatory health. The first subject was dosed on September 19, 2018. The randomized, double-blind, placebo-controlled CHASE clinical trial will evaluate the effect of low-dose and high-dose ZanthoSyn®, Cardax’s premium astaxanthin supplement, on cardiovascular health, as measured […]
MARIETTA, Ohio–(BUSINESS WIRE)–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) Is pleased to announce the launch of a proof of concept study in the field of cardiovascular sciences. Dr. Thomas Pulinilkunnil, Associate Professor, Department of Biochemistry and Molecular Biology, Dalhousie University is the principal investigator on this project. Pulinilkunnil laboratory […]
NEW YORK, Sept. 27, 2018 /PRNewswire/ — TARA Biosystems Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and development applications, announced today the launch of Cardiotype.Fo, the best-in-class in vitrosystem for assessment of cardiac contractility. Contractility of heart muscle tissue is a critically important measure of cardiac function and is used routinely […]
Highlights: • Osprey Medical showcased at the 30th Transcatheter Cardiovascular Therapeutics (TCT) conference with two scientific sessions and moderated abstract sessions focused on awareness and prevention of contrast induced Acute Kidney Injury (AKI) • Osprey Medical featured its Be Kind to Kidneys Program, patient education materials and GE partnership at […]
IRVINE, Calif., Sept. 26, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE :EW ), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced at a 60th anniversary educational event that the Every Heartbeat Matters initiative has exceeded the goal to impact the global burden of heart valve disease […]
WASHINGTON, Sept. 26, 2018 /PRNewswire/ — Six companies presenting innovative medical devices that address significant unmet needs in pediatric healthcare were awarded a total of $150,000 in grants yesterday in Philadelphia, Penn. at the Sixth Annual Pediatric Device Innovation Symposium organized by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System. The “Make Your Medical Device […]
SAN DIEGO, Sept. 25, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced one-year results from a real-world, international, multicenter, 941-patient study of the company’s Portico™ transcatheter aortic valve replacement (TAVR) system in patients with symptomatic, severe aortic stenosis – a life-threatening narrowing of the heart’s aortic valve. At one year, implantation with […]
LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has expanded its OnTrak-A solution into Florida and Georgia with one of the nation’s leading health plans. This follows OnTrak-A’s expansion into Iowa and Nebraska earlier this month. Eligible […]
KFAR-SABA, Israel–(BUSINESS WIRE)–The journal Circulation published results from the CathWorks FFRangio™ FAST-FFR clinical trial in an article titled Accuracy of Fractional Flow Reserve Derived From Coronary Angiography. The publication and trial results were announced today at the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Diego, California. The FAST-FFR trial demonstrated that the […]
